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Lung transplantation with cardiopulmonary 
bypass exaggerates pulmonary vasomotor 
dysfunction in the transplanted lung 
Pulmonary vascular resistance is significantly increased in the transplanted lung. If cardiopulmonary 
bypass is required, the transplanted lung is reperfused with activated blood elements, which might 
exacerbate he reperfusion i jury. The purpose of this study was to examine the influence of cardiopul- 
monary bypass on the following mechanisms of pulmonary vasomotor control in a dog model of 
autologous lung transplantation: (1) endothelium-dependent cyclic gnanosine monophosphate-mediated 
relaxation (response to acetylcholine), (2) endothelium-independent cyclic gnanosine monophosphate- 
mediated relaxation (response to nitroprusside), and (3)/3-adrenergic cyclic adenosine monophosphate- 
mediated relaxation (response to isoproterenol). Autologous right lung transplants were performed with 
(n = 4 dogs) and without (n = 5 dogs) bypass. Lungs were stored in cold saline solution (4 ° C, 3 hours) 
before reimplantation. Pulmonary vasomotor control mechanisms were studied in isolated pulmonary 
arterial rings immediately after harvest and 1 hour after eimplantation. Ten rings were studied in each 
group at each time. Statistical analysis was by analysis of variance. Without bypass, endothelium- 
dependent cyclic guanosine monophosphate-mediated relaxation and /3-adrenergic cyclic adenosine 
monophosphate--mediated relaxation were significantly impaired, although endothelium-independent 
cyclic gnanosine monophosphate-mediated relaxation was not. Use of bypass produced significantly 
greater impairment of both endothelium-dependent cyclic gnanosine monophosphate--mediated relax- 
ation and/3-adrenergic cy lic adenosine monophosphate-mediated relaxation. In addition, use of bypass 
produced significant dysfunction of endothelium-independent cyclic gnanosine monophosphate-medi- 
ated relaxation as well. We conclude that using cardiopulmonary bypass to perform lung transplantation 
greatly exaggerates pulmonary vasomotor dysfunction i the transplanted lung. This dysfunction may 
contribute to significantly higher pulmonary vascular resistance in the transplanted lung if cardiopul- 
monary bypass is used. (J THORAC CARDIOVASC SURG 1995;109:212-7) 
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Lung transplantation requires the transplanted 
lung to endure the injuries of both cold ischemia nd 
reperfusion. Together, these produce pulmonary 
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vasomotor dysfunction in the transplanted lung. 1 
These injuries are associated with an acute rise in 
pulmonary vascular esistance (PVR) in the trans- 
planted lung. 2q2 This increased PVR is largely due 
to avid constriction of the pulmonary vascular 
smooth muscle, even in the absence of hypoxia, a°' 22 
PVR may remain chronically elevated in laboratory 
models of lung transplantation a d is not attribut- 
able to rejection; PVR remains elevated even in 
models of canine autologous lung transplanta- 
tion.9,12 
If cardiopulmonary b pass is necessary for lung 
transplantation, the transplanted lung is reperfused 
with activated blood elements that may exacerbate 
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Fig. 1. Experimental protocol. Pulmonary arterial rings were examined immediately after lung explana- 
tion (control) and 1 hour after lung reimplantation. I  the group in which cardiopulmonary bypass was 
used, bypass was begun 30 minutes before lung reimplantation. The dogs were weaned from bypass 30 
minutes after reimplantation. PGE1, Prostaglandin E 1. 
the reperfusion i jury. We hypothesized that pulmo- 
nary vasomotor dysfunction is exaggerated when 
cardiopulmonary b pass is used for lung transplan- 
tation. The purpose of this study was to examine the 
influence of cardiopulmonary b pass on the follow- 
ing pulmonary vasomotor control mechanisms in a 
canine model o f  autologous lung transplantation: 
(1) endothelium-dependent cyclic guanosine mono- 
phosphate (cGMP)-mediated relaxation (response to 
acetylcholine), (2) endothelium-independent cGMP- 
mediated relaxation (response to sodium nitroprus- 
side), and (3) /3-adrenergic cyclic adenosine mono- 
phosphate (cAMP)-mediated relaxation (response to 
isoproterenol). This study demonstrates that the use of 
cardiopulrnonary b pass to perform lung transplanta- 
tion greatly exaggerates dysfunction of each of these 
mechanisms of pulmonary vasomotor control in the 
transplanted lung. 
Methods 
Surgical protocol. All animals received humane care in 
compliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). 
Right autologous lung transplantation was performed 
through aright thoracotomy incision in mongrel dogs (25 
to 35 kg) after endotracheal intubation and mechanical 
ventilation with pentobarbital nd halothane anesthesia. 
Blood pressure was continuously monitored with an in- 
traarterial catheter. One group of five dogs underwent 
lung transplantation without cardiopulmonary bypass. In 
another group of four dogs the right lung was explanted 
and cardiopulmonary bypass was subsequently initiated 30 
minutes before lung reimplantation. I  the latter group, 
cardiopulmonary bypass was performed with bicaval can- 
nulation and a bubble oxygenator (Cobe Laboratories, 
Denver, Colo.). The experimental protocol is shown in 
Fig. 1. 
After systemic heparinization (250 units&g), prostaglan- 
din E 1 (10/xg/kg) was infused istally into the right main 
pulmonary artery. Then, with the right lung inflated and 
the pulmonary veins vented into the right side of the chest, 
the right main pulmonary artery was occluded proximally 
as modified Euro-Collins solution (4 ° C, 30 ml/kg) was 
infused istally into the right pulmonary artery. With the 
use of a balloon bronchial occluder, the right lung was 
explanted and maintained inflated by clamping the right 
main stem bronchus. It was stored in cold saline solution 
(4 ° C) for 3 hours. Thereafter, the right lung was surgically 
reimplanted with a running monofilament suture tech- 
nique for the bronchial, the arterial, and the venous 
anastomoses. The pulmonary arterial clamp was removed 
and the lung was reperfused and ventilated for approxi- 
mately 1 hour. In the group in which cardiopulmonary 
bypass was used, bypass was begun 30 minutes before lung 
reimplantation. The lung was reperfused and ventilated 
for 30 minutes during bypass. The animals were then 
weaned from bypass and the lung ventilated for an 
additional 30 minutes off bypass. 
Pulmonary artery ring preparation. With the use of a 
dissecting microscope, third-order pulmonary arteries 
(approximately 1 mm in diameter) were dissected from 
each lung and studied at each of two times: (1) immedi- 
ately after harvest (control) and (2) 1 hour after lung 
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Fig. 2. Endothelium-dependent cGMP-mediated vasore- 
laxation. Relaxation by acetylcholine was significantly 
impaired in the transplanted lung without use of cardio- 
pulmonary bypass. This dysfunction was significantly ex- 
aggerated by the use of.cardiopulmonary bypass, n = 10 
rings in each group. Values are mean _+ standard error of 
the mean. *p < 0.05 compared with control, tp < 0.05 
versus without use of cardiopulmonary bypass. 
reimplantation. Under dissecting microscope magnifica- 
tion, the surrounding tissue was dissected from the pul- 
monary arteries. The pulmonary arteries were then cut 
into rings, each ring being 3 to 4 mm wide. Great care was 
taken during this process to avoid endothelial injury. The 
pulmonary arterial rings were suspended on fine wire 
tensiometers in individual 10 ml organ chambers. The 
organ chambers were surrounded by water jackets and 
continually warmed to 37 ° C. Ring tension was deter- 
mined by use of a force-displacement transducer (Grass 
FTO3, Grass Instruments Co., Quincy, Mass.) attached to 
each tensiometer apparatus. Ring tension was thereby 
recorded with a MacLab data interface module (ADI 
Instruments, Milford, Mass.) on a Macintosh Ilci com- 
puter (Apple Computer, Inc, Cupertino, Calif.). The organ 
chambers were filled with Earle's balanced salt solution and 
continuously bubbled with gas consisting of 21% oxygen, 5% 
carbon dioxide, and balanced nitrogen. Earle's balanced salt 
solution is a standard physiologic salt solution and contains 
CaC12 1.80 mmol/L, MgSO4 (anhydrous) 0.83 mmol/L, KC1 
5.36 retool/L, NaC1 116.34 retool/L, NaPO4 0.40 mmol/L 
(dibasic), o-glucose 5.50 mmol/L, NaHCO3 19.04 mmol/L, 
and phenol red Na 0.03 mmol/L (as pH indicator). The 
oxygen tension of the bath was 100 to 110 mm Hg and the 
pH was 7.35 to 7.45. 
In a separate series of experiments, he concentration f 
acetylcholine, sodium nitroprusside, and isoproterenol 
required to produce complete relaxation of isolated ca- 
nine pulmonary arterial rings was determined tobe 10 -6 
mol/L for each agent. The rings in this study were allowed 
to reach a steady state (approximately 90minutes) at a 
baseline tension of 750 mg. The rings were then precon- 
stricted with phenylephrine 10 -6 mol/L to study the vasore- 
laxing effects of acetylcholine 10-6 mol/t ,  sodium nitroprus- 
side 10 -6 tool/L, and isoproterenol 10-6 mol / t  in each ring 
in a random order. Once ring tension reached a steady state 
in response to phenylephrine, a given vasorelaxing a ent was 
added to the organ chamber. After each agent was tested, 
the organ chambers were flushed several times and the rings 
were allowed to reach a steady state before being precon- 
stricted once again with phenylephrine to test the next 
vasorelaxing agent. Ten pulmonary arterial rings in each 
group were studied at the point of data collection. Data are 
presented as the percent relaxation of phenylephrine-in- 
duced ring tension produced by the given vasorelaxing a ent. 
Values are expressed as mean plus or minus one standard 
error of the mean. Statistical nalysis was done by analysis of 
variance (Scheffe's F test). A p value of less than 0.05 was 
considered statistically significant. 
Results 
Pulmonary vasomotor dysfunction was greatly ex- 
aggerated when cardiopulmonary b pass was used 
to perform lung transplantation. Immediately after 
lung harvest, acetylcholine 10 -6 mol/L produced 
95% + 5% relaxation, sodium nitroprusside 20 -6 
mol/L produced 98% + 2% relaxation, and isopro- 
terenol 10 -6 mol/L produced 92% + 5% relaxation 
in control vessels. Without the use of cardiopulmo- 
nary bypass, endothelium-dependent cGMP-medi- 
ated relaxation was significantly impaired because 
acetylcholine produced only 46% _+ 10% relaxation 
(p < 0.05 versus control). This dysfunction was 
significantly exaggerated by the use of cardiopulmo- 
nary bypass: acetylcholine produced only 8% + 6% 
relaxation (p < 0.05 versus without bypass) (Fig. 2). 
On the other hand, endothelium-independent 
cGMP-mediated relaxation was not impaired with- 
out the use of cardiopulmonary bypass: sodium 
nitroprusside produced 95% + 4% relaxation. How- 
ever, cardiopulmonary b pass resulted in significant 
dysfunction of this mechanism of pulmonary vasore- 
laxation because sodium nitroprusside produced 
only 43% + 6% relaxation if bypass was used (p < 
0.05 versus without bypass) (Fig. 3). 
/3-Adrenergic cAMP-mediated vasorelaxation was 
significantly impaired even without the use of car- 
diopulmonary bypass: isoproterenol produced 38% 
+ 6% relaxation (p < 0.05 versus control). This 
dysfunction was also significantly exaggerated bythe 
use of cardiopulmonary b pass. If bypass was used, 
isoproterenol produced only 22% + 5% relaxation 
(p < 0.05 versus without bypass) (Fig. 4). 
Discussion 
The ischemic and reperfusion i juries incurred by 
the transplanted lung produce significant dysfunc- 
tion of the mechanisms of pulmonary vasorelax- 
ation) The results of the present study demonstrate 
that this vasomotor dysfunction is significantly exag- 
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Fig. 3. Endothelium-independent cGMP-mediated vaso- 
relaxation. Relaxation by sodium nitroprusside was not 
impaired in the transplanted lung without use of cardio- 
pulmonary bypass. However, use of cardiopulmonary by-
pass resulted in significant dysfunction,  = 10 rings in 
each group. Values are mean +- standard error of the 
mean. *p < 0.05 compared with control. ?p < 0.05 versus 
without use of cardiopulmonary bypass. 
gerated if cardiopulmonary b pass is used to per- 
form the lung transplant operation. 
The principal intracellular mechanisms ofpulmo- 
nary vascular smooth muscle relaxation are ulti- 
mately mediated through adenosine 3',5'-cyclic 
monophosphate (cAMP) or guanosine 3',5'-cyclic 
monophosphate (cGMP). 13 In response to activa- 
tion of receptors on pulmonary vascular smooth 
muscle cells (such as /3-adrenergic receptors), pul- 
monary vascular smooth muscle adenylate cyclase 
generates cAMP, which in turn effects pulmonary 
vasorelaxation. 14 On the other hand, cGMP-medi- 
ated relaxation may be either endothelium depen- 
dent or endothelium independent. Agents such as 
acetylcholine produce pulmonary vascular smooth 
muscle relaxation by binding to muscarinic receptors 
on pulmonary vascular endothelium. In response, 
the pulmonary vascular endothelium releases endo- 
thelium-derived relaxing factor, which is thought to 
be nitric oxide. Endothelium-derived r laxing factor 
in turn activates guanylate cyclase within the pulmo- 
nary vascular smooth muscle cellJ 3 The cGMP 
thereby produced via guanylate cyclase effects pul- 
monary vascular smooth muscle relaxation. On the 
other hand, sodium nitroprusside is a functional 
analog of endothelium-derived r laxing factor and 
directly activates pulmonary vascular smooth muscle 
guanylate cyclase to produce cGMP independently 
of the endotheliumJ 3 
In this study, dysfunction of cGMP- as well as 
cAMP-mediated pathways of pulmonary vasorelax- 
e~ 
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Fig. 4. 13-AdrenergiccAMP-mediatedvasorelaxation.Re- 
laxation by isoproterenol was significantly impaired in the 
transplanted lung without use of cardiopulmonary bypass. 
This dysfunction was significantly exaggerated by the use 
of cardiopulmonary bypass, n = 10 rings in each group. 
Values are mean + standard error of the mean. *iv < 0.05 
compared with control, tP < 0.05 versus without use of 
cardiopulmonary bypass. 
ation were exaggerated bythe use of bypass. If the 
mechanisms of pulmonary vasorelaxation are dys- 
functional, the balance of pulmonary vascular tone 
may be shifted toward a net constriction. In addi- 
tion, dysfunction of the mechanisms of relaxation 
allow for an exaggerated response to vasoconstrict- 
ing agents uch as hypoxia. 15' 16 Therefore, impaired 
pulmonary vasorelaxation may result in increased 
PVR. 
Cardiopulmonary bypass is known to activate 
complement 17 and neutrophils s'19 and to increase 
circulating levels of cytokines such as endotoxin, 19' 2o 
interleukins,21, 22 and tumor necrosis factor. 2° When 
cardiopulmonary b pass is used for lung transplan- 
tation, not only is the pulmonary vascular bed 
subjected to protracted cold ischemia, but the reper- 
fusate may reasonably be expected to produce 
greater eperfusion i jury than when bypass is not 
used. This may explain the significantly greater 
pulmonary vasomotor dysfunction produced with 
the use of bypass in the present study. Further, 
circulating levels of vasoconstricting substances are 
increased with bypass. 22 If mechanisms of pulmo- 
nary vasorelaxation are impaired in the transplanted 
lung, these agents may have even greater vasocon- 
stricting effects. 
In summary, pulmonary vasomotor dysfunction 
was greatly exaggerated when cardiopulmonary b - 
pass was used to perform lung transplantation. 
Impairment of both endothelium-dependent and
-independent cGMP-mediated mechanisms as well 
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as/3-adrenergic cAMP-mediated pulmonary vasore- 
laxation was significantly greater than when cardio- 
pulmonary bypass was not used. These findings 
suggest that a greater rise in PVR in the trans- 
planted lung may occur if cardiopulmonary b pass is 
used to perform the procedure. 
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Discussion 
Dr. Glenn J. R. Whitman (Philadelphia, Pa.). What 
happens to the contralateral lung that has not undergone 
preservation? What kind of vasomotor dysfunction, if any, 
does that lung have? More simply phrased, what is the 
effect of cardiopulmonary b pass on lungs after any heart 
procedure? 
Dr. Fullerton. In the contralateral lung there is no 
dysfunction of any of the mechanisms of pulmonary 
vasomotor control as studied in this model. A variety of 
circulating vasoconstricting a ents are present, but with- 
out inducing an ischemic injury in the lung, followed by a 
reperfusion i jury, we fail to find any dysfunction of these 
mechanisms in the contralateral lung. 
Dr. Robert A. Guyton (Atlanta, Ga.). I have a couple of 
questions about the mechanisms of cardiopulmonary b - 
pass. First, was any donor blood used in the cardiopulmo- 
nary bypass circuit? I presume this was hemodilution 
without exogenous protein administration. Second, in 
most of our dog models we give steroids and antihistamine 
(Benadryl) to reduce the inflammatory response. What 
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were the conditions of your cardiopulmonary bypass 
setup? 
Dr. Fullerton. We did not use exogenous blood in the 
animals. The starting hematocrit values were between 
42% and 48% and were lowered by hemodilution to the 
mid-20s. In one dog the hematocrit value was actually 
lowered to 18%. 
We used a bubble oxygenator with a pediatric setup and 
bicaval cannulation, of course, to allow total bypass. We 
did not pretreat the animals with anything. 
Dr. Anthony L. Moulton (Providence, R.L). Do you 
think there are any implications from this study about the 
multiple organ donor (including lung donation) in whom 
cardiopulmonary b pass and deep hypothermia are used? 
Dr. Fullerton. I have not thought about that. If I were 
to speculate, I do not think there would be much differ- 
ence in the vasoreactivity of the arteries if deep hypother- 
mia was used to harvest he organs. I think that would 
protract the cold ischemic injury that we provide clinically, 
but the injury probably would be comparable. 
In another study that we have performed, both in 
pulmonary arteries and in coronary arteries, we found that 
this dysfunction isproduced on reperfusion of the vascular 
bed. Dr. Wechsler's group likewise has shown that little 
vasomotor dysfunction is produced in models of pro- 
tracted cold ischemia. Thus, assuming that in the donor 
that you described the deep hypothermia merely provided 
a longer period of cold ischemia, I do not think there 
would be much difference from what we have seen here. 
Dr. John E. Mayer (Boston, Mass.). I suppose the other 
way of interpreting this is that the vessels that you have 
are more highly sensitive to the preconstricting phe- 
nylephrine that you gave. I presume that you precon- 
stricted all of the vessels to a given tension, or you set the 
tension, but you must also have some idea about the 
dimension to which the vessel is prestretched, aswell. Do 
you think either of those two mechanisms i operative? 
Dr. Fullerton. You have pointed out an important 
technical aspect in using this technique. It is important to 
preconstrict rings of any vascular bed to approximately the 
same level of tension. In this study all the rings were 
preconstricted to between 350 and 500 mg of active 
tension in response to phenylephrine. 
As it turns out, the dose-response curve to phenyleph- 
fine in the group undergoing cardiopulmonary b pass is 
shifted a bit to the left, indicating a greater esponse to a 
vasoconstricting a ent. We think this response is associ- 
ated with or perhaps even related to a dysfunction in the 
mechanisms of relaxation. However, for the purposes of 
the study, the rings are constricted to the same levels of 
tension in each group, which allows the data to be 
presented as a percentage. 
We examined vessels that are about 1 mm in diameter, 
the upper limit being about 1.2 mm. For this technique, 
that is about he smallest vessel that we can study with this 
apparatus. We were not studying the microvascular bed, 
which is significantly more difficult to do successfully in 
the lung than in other organ beds. However, the results in 
this caliber of vessel are very similar to results of infusion 
of these agents into the intact animal. We therefore 
believe the data represent what happens at the microvas- 
cular level. 
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